Contact
Please use this form to send email to PR contact of this press release:
Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD
TO:
Please use this form to send email to PR contact of this press release:
Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD
TO: